Javitt Daniel C.
- SEC CIK
- 0001864534
No open-market purchases or sales filed in the past year.
Current role at each company
- NRXP NRX Pharmaceuticals, Inc.10% Owneras of Dec 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Javitt Daniel C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 (view filing) | Nov 29-30 | 2 days | Javitt Daniel C.10% Owner | SSale | −22.2K | $1.50 | −$33.3K | −0.2%9.63M after | 2 lots |
| Nov 18, 2022 (view filing) | Nov 16-17 | 2 days | Javitt Daniel C.10% Owner | SSale | −166.7K | $1.03 | −$171.1K | −1.7%9.66M after | 2 lots |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Javitt Daniel C.10% Owner | SSale | −49.2K | $1.01 | −$49.7K | −0.5%9.82M after | |
| Aug 2, 2022 (view filing) | Jul 29 | 4 days | Javitt Daniel C.10% Owner | SSale | −784.1K | $1.01 | −$791.9K | −7.4%9.87M after | |
| Jun 7, 2022 (view filing) | Jun 3-7 | 4 days | Javitt Daniel C.10% Owner | SSale | −445.7K | $0.6825 | −$304.2K | −3.4%12.7M after | 3 lots |